mirikizumab
eli lilly
['lucent-1', ' aa ', 'mirikizumab', 'lucent-2', ' uc ']
bowel urgency outcomes are associated with improvement in fatigue in uc: a pooled analysis of lucent-1 &amp; 2 (mirikizumab) presented by nice to consider bowel urgency and fatigue as outcomes as they entail big qol impact
#ddw2023 #agalive2023 
Celebrate life. Gastroenterologist #IBD passionate. Help others grow their abilities. https://t.co/4V0xhhdIti